Additional programme information

Please find the additional information about the programme below.



This programme aims to support the development of staff and improvement of GP practice processes to deliver pharmacotherapy services as outlined in the Memorandum of Understanding 2: GMS Contract Implementation for Primary Care Improvement (2021). The Royal Pharmaceutical Society Scotland and British Medical Association’s joint statement supports that full delivery of pharmacotherapy services is essential to improving primary care for patients, GP practice staff and pharmacists.

The Scottish Government Primary Care division commissions and funds the Pharmacotherapy programme to support Pharmacotherapy service implementation which is a key priority in both 2018 GMS contract and recently updated Memorandum of Understanding 2 agreement between the Scottish GP Committee of British Medical Association (BMA) Scotland and the Scottish Government.

The Scottish Patient Safety Programme (SPSP) is a national quality improvement programme that aims to improve the safety and reliability of care and reduce harm. Commissioned by Scottish Government and delivered by Healthcare Improvement Scotland’s ihub, the programme had an initial focus on acute hospitals, but now includes safety improvement programmes for Acute Adult, Primary Care, Maternity and Children, Medicines and Mental Health.


Equality impact assessment

To ensure everyone can benefit regardless of their characteristics or where they access care, we completed an Equality Impact Assessment. This highlights key equality issues that were considered and any actions we took in relation to them.